Synthesising evidence of the effects of COVID regulatory changes on methadone treatment for OUD

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy, in The Lancet Public Health

key takeaway: "Efforts to create a permanent policy to support increased flexibility of take-home doses, with the goal of improved patient outcomes, are well supported."